Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers. 1981

M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy

Intracellular electrophysiological studies were performed on isolated canine cardiac tissues to investigate further the reported ability of clofilium (3 X 10(-8)--10(-6) M) to selectively increase action potential duration (APD) and refractoriness. In Purkinje fibers from normal dogs, clofilium did not influence (1) the rate of rise of the action potential (Vmax) elicited from normal or depolarized (10 mM potassium) resting potentials, (2) the Vmax of premature potentials elicited during the repolarization phase of a previous action potential or (3) the rate of diastolic depolarization of spontaneously firing Purkinje fibers. The diastolic interval was altered by inserting a single premature impulse during diastole or by varying the basic cycle length. Clofilium (3 X 10(-7) M) slightly reduced the time constant for the relation between diastolic interval and APD in concentrations that caused a maximal increase in APD of nonpremature impulses. In dogs subjected to occlusion of the left anterior descending coronary artery 48 hr before study, the APD of surviving Purkinje fibers was longer in the infarcted zone than in the normal zone. Clofilium (3 X 10(-8) M) increased APD in both zones but more so in the normal areas, thus reducing the disparity of APD between zones. Similarly, clofilium (3 X 10(-8) and 3 X 10(-7) M) increased the effective refractory period in both zones but more so in the normal area. The increase of APD and refractoriness in normal as well as depolarized or ischemic tissues in the absence of marked changes in Vmax and conduction may decrease the likelihood of reentrant arrhythmias and underlie the antifibrillatory effects in anesthetized dogs.

UI MeSH Term Description Entries
D008297 Male Males
D011690 Purkinje Fibers Modified cardiac muscle fibers composing the terminal portion of the heart conduction system. Purkinje Fiber,Fiber, Purkinje,Fibers, Purkinje
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000644 Quaternary Ammonium Compounds Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN Quaternary Ammonium Compound,Ammonium Compound, Quaternary,Ammonium Compounds, Quaternary,Compound, Quaternary Ammonium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
April 1987, Journal of cardiovascular pharmacology,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
February 1984, The American journal of physiology,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
February 1988, Journal of the American College of Cardiology,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
December 1982, Journal of chromatography,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
September 1988, Journal of cardiovascular pharmacology,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
July 1989, Canadian journal of physiology and pharmacology,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
October 1979, Life sciences,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
January 1985, Journal of electrocardiology,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
May 1985, European journal of pharmacology,
M I Steinberg, and M E Sullivan, and S A Wiest, and F W Rockhold, and B B Molloy
February 2000, General pharmacology,
Copied contents to your clipboard!